Brecrus 10%

Brecrus 10% Uses, Dosage, Side Effects, Food Interaction and all others data.

Brecrus 10% is an antiallergic drug developed by Kissei Pharmaceuticals. In 1982, it was approved in Japan and South Korea for the management of bronchial asthma. Indications for keloid and hypertrophic scar were added in 1993. It has been used for the treatment of allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.

Trade Name Brecrus 10%
Generic Tranilast
Tranilast Other Names Tranilast, Tranilastum
Type
Formula C18H17NO5
Weight Average: 327.3313
Monoisotopic: 327.110672659
Groups Investigational
Therapeutic Class
Manufacturer
Available Country Japan
Last Updated: September 19, 2023 at 7:00 am
Brecrus 10%
Brecrus 10%

Uses

For the treatment of bronchial asthma, keloid and hypertrophic scar, and allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.

Innovators Monograph

You find simplified version here Brecrus 10%

*** Taking medicines without doctor's advice can cause long-term problems.
Share